Science Explorer Interactive view Map
Company · Burnaby · Canada

Arbutus Biopharma (Canada)

arbutusbio.comROR OpenAlex
Research works
49
▲ 10% vs 2013–17
Citations
3.5k
71.5 per fractional work
Top-10% rate
6.8%
record average 16.5%
Open access
37%
world 28%

Not ranked overall: Arbutus Biopharma (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Neuroscience: 1.39× its world share, 0 worksNeuroscienceComputer Science: 2.95× its world share, 2 worksComputer ScienceEngineering: 0.60× its world share, 1 worksEngineeringMedicine: 1.13× its world share, 2 worksMedicineBusiness, Management and Accounting: 5.61× its world share, 1 worksBusiness, Management…Social Sciences: 2.05× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Business, Management and Accounting, 5.6×. Every wedge is a field page.

Which keywords describe research at Arbutus Biopharma (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Immune Response, RNA Interference, siRNA Delivery, Antiviral Therapy, Liver Disease, Hepatocellular Carcinoma and Epidemiology.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Gene Therapy6▲ 44×3 topics
  2. Immune Response6▲ 18×7 topics
  3. Epidemiology4▲ 2.3×12 topics
  4. RNA Interference4▲ 82×1 topic
  5. siRNA Delivery4▲ 122×1 topic
  6. Antiviral Therapy4▲ 55×2 topics
  7. Liver Disease4▲ 60×2 topics
  8. Hepatocellular Carcinoma2▲ 23×2 topics
  9. Immunity2▲ 14×3 topics
  10. Innate Immunity2▲ 14×3 topics
  11. Vaccine2▲ 12×5 topics
  12. Treatment2▲ 3.5×3 topics
  13. Chronic Hepatitis B2▲ 78×1 topic
  14. Hepatitis B Virus2▲ 78×1 topic
  15. Hepatitis C Virus2▲ 79×1 topic
  16. Pattern Recognition Receptors2▲ 28×2 topics
  17. Ribavirin2▲ 79×1 topic
  18. Nanoparticles2▲ 3.0×4 topics
  19. Antigen Presentation2▲ 36×1 topic
  20. Cancer Immunotherapy2▲ 26×2 topics
  21. Dendritic Cells2▲ 31×1 topic
  22. Pathogenesis2▲ 6.5×5 topics
  23. Digital Literacy2▲ 11×3 topics
  24. Pathogen Recognition2▲ 39×2 topics
  25. Sustainability2▲ 1.88×5 topics
  26. Innate Antiviral Responses2▲ 45×1 topic
  27. Toll-like Receptors2▲ 18×1 topic
  28. Cancer Therapy1▲ 4.3×5 topics
  29. RNA methylation1▲ 33×1 topic
  30. m6A-seq1▲ 33×1 topic
  31. Quality of Service1▲ 35×2 topics
  32. Risk Management1▲ 7.3×2 topics
  33. BIM1▲ 50×1 topic
  34. Construction1▲ 20×1 topic
  35. Ebola Virus1▲ 95×1 topic
  36. Educational Challenges1▲ 185×1 topic
  37. Information Technology1▲ 6.6×2 topics
  38. NK Cell Recognition1▲ 20×1 topic
  39. Natural Killer Cells1▲ 20×1 topic
  40. Outbreak1▲ 63×1 topic

Which research topics does Arbutus Biopharma (Canada) publish most on?

By volume in 2022–2025: Management and Optimization Techniques, Decision Support System Applications, Computational Drug Discovery Methods and Hepatitis C virus research.

Management and Optimizat…0Management and Optimization Techniques: 0 fractional worksDecision Support System …0Decision Support System Applications: 0 fractional worksComputational Drug Discovery Methods: 0 fractional worksHepatitis C virus research0Hepatitis C virus research: 0 fractional worksHepatitis B Virus Studies0Hepatitis B Virus Studies: 0 fractional worksICT in Developing Communities: 0 fractional worksGovernance, Compliance, and Sustainability: 0 fractional worksGenerational Differences…0Generational Differences and Trends: 0 fractional worksEducation, Sociology, Communication Studies: 0 fractional worksSpeech and dialogue systems: 0 fractional works
Strategy and ManagementManagement Information SystemsComputational Theory and MathematicsHepatology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Management and Optimization Techniques Strategy and Management 0 works
  2. 2 Decision Support System Applications Management Information Systems 0 works
  3. 3 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  4. 4 Hepatitis C virus research Hepatology 0 works
  5. 5 Hepatitis B Virus Studies Epidemiology 0 works
  6. 6 ICT in Developing Communities Information Systems 0 works
  7. 7 Governance, Compliance, and Sustainability Strategy and Management 0 works
  8. 8 Generational Differences and Trends Life-span and Life-course Studies 0 works
  9. 9 Education, Sociology, Communication Studies Cultural Studies 0 works
  10. 10 Speech and dialogue systems Artificial Intelligence 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.8%not open63.2%

World: 28% of research is openly available.

with international co-authors41.8%domestic only58.2%

World: 19% is written across borders.

How has Arbutus Biopharma (Canada)'s research output changed?

Output in 2018–2022 was 10% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Burnaby

All research institutions in Burnaby

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.